# Nuclide record f-18-flurpiridaz (drug). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/drugs/f-18-flurpiridaz/>
  a schema:Drug ;
  nuclide:kind "drug" ;
  schema:identifier "f-18-flurpiridaz" ;
  schema:name "Flurpiridaz F-18"@en ;
  schema:alternateName "18F-flurpiridaz"@en, "BMS-747158-02"@en, "Flyrcado" ;
  schema:description "The newest heart PET tracer, approved in the US in September 2024. It sticks tightly to a protein inside heart-muscle mitochondria in proportion to blood flow, lasts long enough to be made off site and shipped like a hospital's regular PET drug, and is the first cardiac PET tracer practical to pair with a treadmill exercise test."@en ;
  schema:url <https://nuclide.cc/drugs/f-18-flurpiridaz/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/drugsatfda_docs/nda/2024/215168Orig1s000Approv.pdf>, <https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/215168s000lbl.pdf>, <https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-imaging-drug-evaluation-myocardial-ischemia-and-infarction>, <https://snmmi.org/common/Uploaded%20files/Web/Clinical%20Practice/Procedure%20Standards/2025/Flurpiridaz%20Procedure%20Standard-JNM.pdf> ;
  nuclide:tag "PET", "myocardial perfusion", "mitochondrial complex I" ;
  nuclide:modality "PET tracer" ;
  nuclide:approval "US 2024: PET myocardial perfusion imaging (MPI) under rest or stress (pharmacologic or exercise) in adult patients with known or suspected coronary artery disease, to evaluate for myocardial ischaemia and infarction" ;
  nuclide:related <https://nuclide.cc/drugs/rb-82-chloride/>, <https://nuclide.cc/drugs/n-13-ammonia/>, <https://nuclide.cc/drugs/tc-99m-sestamibi/>, <https://nuclide.cc/isotopes/f-18/>, <https://nuclide.cc/isotopes/n-13/>, <https://nuclide.cc/isotopes/rb-82/> ;
  nuclide:indications <https://nuclide.cc/indications/coronary-artery-disease/> ;
  nuclide:companies <https://nuclide.cc/companies/ge-healthcare/> .